Stem Cell Banking Market by Type and Geography - Forecast and Analysis 2021-2025

  • Published: Jan 2022
  • Pages: 120
  • SKU: IRTNTR71861
Technavio

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The stem cell banking market share is expected to increase by USD 4.61 billion from 2020 to 2025, and the market’s growth momentum will accelerate at a CAGR of 8.08%.

This stem cell banking market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers stem cell banking market segmentation by type (adult stem cells, umbilical cord blood stem cells, and embryonic stem cells) and geography (North America, Europe, Asia, and ROW). The stem cell banking market report also offers information on several market vendors, including Cordlife Group Ltd., CordVida, Covis Pharma BV, Cryo Stemcell, Cryo-Cell International Inc., Cryoviva Biotech Pvt. Ltd., FUJIFILM Holdings Corp., Global Cord Blood Corp., PerkinElmer Inc., and Plus Therapeutics Inc. among others.

What will the Stem Cell Banking Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Stem Cell Banking Market Size for the Forecast Period and Other Important Statistics

 

Stem Cell Banking Market: Key Drivers and Trends

The increased federal investment in stem cell therapy is notably driving the stem cell banking market growth, although factors such as high operational costs may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the stem cell banking industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Stem Cell Banking Market Driver

One of the key factors driving growth in the stem cell banking market is the increased federal investment in stem cell therapy. Many research institutions and small vendors cannot afford to invest in stem cell therapy-related services, as research and clinical trials of stem cell therapy are expensive. Government organizations have realized the importance and potential of stem cell research and increased their funding for these studies. Many state-oriented organizations also provide funding for stem cell studies. Thus, the rising investments in stem cell research will increase the demand for stem cell banking during the forecast period.

Key Stem Cell Banking Market Challenge

The high operational costs will be a major challenge for the stem cell banking market during the forecast period. These costs cannot be met by patients and act as a barrier to the entry of new vendors into the market. The associated costs are usually more pronounced with private cord blood banks. For example, Private cord blood banking is expensive. You will pay a starting fee of about $1,000 to $2,000, plus a storage fee of more than $100 a year for as long as the blood is stored. Stem cell banking service is also expensive in Europe, which has the greatest number of stem cell banks in the world. The cost of preservation of stem cells is quite high at $2,000-$2,500 for 20 years, which does not include the cost of possible therapies later. Hence, with such high costs, families may not opt for stem cell banking even with the awareness about possible medical benefits. This will affect the growth of the market during the forecast period.

This stem cell banking market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Who are the Major Stem Cell Banking Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Cordlife Group Ltd.
  • CordVida
  • Covis Pharma BV
  • Cryo Stemcell
  • Cryo-Cell International Inc.
  • Cryoviva Biotech Pvt. Ltd.
  • FUJIFILM Holdings Corp.
  • Global Cord Blood Corp.
  • PerkinElmer Inc.
  • Plus Therapeutics Inc.

 

This statistical study of the stem cell banking market encompasses successful business strategies deployed by the key vendors. The stem cell banking market is fragmented and the vendors are deploying growth strategies such as aiming to expand their customer base by getting key accreditations for their services and products from major global certification authorities to compete in the market.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The stem cell banking market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Stem Cell Banking Market?

For more insights on the market share of various regions Request for a FREE sample now!

39% of the market’s growth will originate from North America during the forecast period. US and Canada are the key markets for stem cell banking in North America. Market growth in this region will be slower than the growth of the market in the European and Asian regions.

The presence of a well-developed healthcare system will facilitate the stem cell banking market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

What are the Revenue-generating Type Segments in the Stem Cell Banking Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The stem cell banking market share growth by the adult stem cells segment will be significant during the forecast period. The adult stem cell banking segment leads the market owing to the easy availability of these cells within the human body. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the stem cell banking market size and actionable market insights on post COVID-19 impact on each segment.

 

Stem Cell Banking Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 8.08%

Market growth 2021-2025

$ 4.61 billion

Market structure

Fragmented

YoY growth (%)

7.22

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 39%

Key consumer countries

US, Canada, Germany, UK, China, and India

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Cordlife Group Ltd., CordVida, Covis Pharma BV, Cryo Stemcell, Cryo-Cell International Inc., Cryoviva Biotech Pvt. Ltd., FUJIFILM Holdings Corp., Global Cord Blood Corp., PerkinElmer Inc., and Plus Therapeutics Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Stem Cell Banking Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive stem cell banking market growth during the next five years
  • Precise estimation of the stem cell banking market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the stem cell banking industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of stem cell banking market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

Executive Summary

    Market Landscape

    • Market ecosystem
    • Value chain analysis

    Market Sizing

    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025

    Five Forces Analysis

    • Five forces summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition

    Market Segmentation by Type

    • Market segments
    • Comparison by Type
    • Adult stem cells - Market size and forecast 2020-2025
    • Umbilical cord blood stem cells - Market size and forecast 2020-2025
    • Embryonic stem cells - Market size and forecast 2020-2025
    • Market opportunity by Type

    Customer landscape

      Geographic Landscape

      • Geographic segmentation
      • Geographic comparison
      • North America - Market size and forecast 2020-2025
      • Europe - Market size and forecast 2020-2025
      • Asia - Market size and forecast 2020-2025
      • ROW - Market size and forecast 2020-2025
      • Key leading countries
      • Market opportunity by geography
      • Market drivers
      • Market challenges
      • Market trends

      Vendor Landscape

      • Overview
      • Vendor landscape
      • Landscape disruption

      Vendor Analysis

      • Vendors covered
      • Market positioning of vendors
      • Cordlife Group Ltd.
      • CordVida
      • Covis Pharma BV
      • Cryo Stemcell
      • Cryo-Cell International Inc.
      • Cryoviva Biotech Pvt. Ltd.
      • FUJIFILM Holdings Corp.
      • Global Cord Blood Corp.
      • PerkinElmer Inc.
      • Plus Therapeutics Inc.

      Appendix

      • Scope of the report
      • Currency conversion rates for US$
      • Research methodology
      • List of abbreviations

      Research Framework

      Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

      TechnavioINFORMATION SOURCES

      Primary sources

      • Manufacturers and suppliers
      • Channel partners
      • Industry experts
      • Strategic decision makers

      Secondary sources

      • Industry journals and periodicals
      • Government data
      • Financial reports of key industry players
      • Historical data
      • Press releases
      Technavio

      TechnavioDATA ANALYSIS

      Data Synthesis

      • Collation of data
      • Estimation of key figures
      • Analysis of derived insights

      Data Validation

      • Triangulation with data models
      • Reference against proprietary databases
      • Corroboration with industry experts
      Technavio

      TechnavioREPORT WRITING

      Qualitative

      • Market drivers
      • Market challenges
      • Market trends
      • Five forces analysis

      Quantitative

      • Market size and forecast
      • Market segmentation
      • Geographical insights
      • Competitive landscape
      Interested in this report?
      Get your FREE sample now!
      The stem cell banking market growth will increase by $4615.31 million during 2020-2025.
      The stem cell banking market is expected to grow at a CAGR of 8.08% during 2020-2025.
      Technavio has segmented the stem cell banking market by type (Adult stem cells, Umbilical cord blood stem cells, and Embryonic stem cells) and geographic (North America, Europe, Asia, and ROW).
      Cordlife Group Ltd., CordVida, Covis Pharma BV, Cryo Stemcell, Cryo-Cell International Inc., Cryoviva Biotech Pvt. Ltd., FUJIFILM Holdings Corp., Global Cord Blood Corp., PerkinElmer Inc., Plus Therapeutics Inc. are a few of the key vendors in the stem cell banking market.
      North America will register the highest growth rate of 39.26% among the other regions. Therefore, the stem cell banking market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
      • US
      • Canada
      • Germany
      • UK
      • China
      • India
      The key factors driving the stem cell banking market growth are:
      • Increased federal investment in stem cell therapy
      The stem cell banking market vendors should focus on grabbing business opportunities from the adult stem cells segment as it accounted for the largest market share in the base year.
      Safe and Secure SSL Encrypted
      Technavio

      Single User:

      2500 USD

      Technavio Get the report (PDF) sent to your email within minutes.

      Subscribe & Save

      Get lifetime access to our
      Technavio Insights

      Want to customize this report?

      This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

      We offer $1000 worth of FREE customization at the time of purchase
      Technavio
      Enquire Before Buying
      1. Home
      2. Health Care
      3. Published Report
      17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>